# srk bio pharma

> Reevol Source machine-readable supplier card. Profile URL: https://source.reevol.com/zh-Hant/suppliers/srk-bio-pharma/. Locale: zh-Hant.

## Profile status
- Unclaimed profile. The details below come from public business registries, trade-fair exhibitor lists and certification bodies, and have not yet been confirmed by the company itself. Fields that are absent here are unconfirmed, not negative findings.
- The company can claim this profile free at https://source.reevol.com/zh-Hant/claim/srk-bio-pharma/ to confirm and complete it.

## Identity
- Legal name (en): srk bio pharma
- Business type: manufacturer
- Location: India

## Industry
- Primary: Pharmaceuticals
- Sub-industries: APIs, Intermediates, Impurities, Dosage Formulations, Trimetazidine Hydrochloride, Telmisartan, Olemesartan, Candey Sartan, Darunavir, Custom Synthesis
- HS codes: 3004, 2934, 3002

## Digital footprint

## Summary
What we know: 位於印度的製藥API、中間體和劑型製劑製造商（已按國家和業務類型驗證） 生產活性製藥成分，包括三甲基二嗪鹽酸鹽、替米沙坦、達魯那韋和定製合成服務（已按產業標籤驗證） HS編碼3004、2934和3002與製藥產品和有機化合物相符（已按HS編碼驗證）

What the data suggests: 考慮到對API和替米沙坦、達魯那韋等品牌仿製藥的關注，可能出口到受管制市場（由產業標籤和HS編碼建議） 可能在標準製藥製造之外經營定製合成能力（由定製合成標籤建議）

Data flags: 印度境内的具体位置未經驗證。可能影響物流規劃、海關路由和審計可行性。

Not yet verified: 網站, 認證, 貿易展會, 出口市場, 生產能力.

在聯絡前驗證srk bio pharma - Reevol在24小時內返回驗證簡報。

## Provenance
- Last enriched: 2026-08-31T06:35:41.428Z
- AI content last generated: 2026-08-31T07:33:15.260Z
- Source: Reevol Source (https://source.reevol.com). Underlying data from Reevol, sourced from public business registries, trade-fair exhibitor lists, certification bodies, and digital footprint.
- License: see https://source.reevol.com/zh-Hant/methodology/